Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AnaptysBio Inc. (ANAB)

11.04   -0.04 (-0.36%) 11-19 16:00
Open: 11.26 Pre. Close: 11.08
High: 11.33 Low: 10.9316
Volume: 797,835 Market Cap: 300M
AnaptysBio Inc is a biotechnology company. The Company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.344 - 11.414 11.414 - 11.464
Low: 10.764 - 10.851 10.851 - 10.913
Close: 10.925 - 11.053 11.053 - 11.144

Technical analysis

as of: 2019-11-19 4:24:13 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 32.96     One year: 46.11
Support: Support1: 10.00    Support2: 8.32
Resistance: Resistance1: 28.22    Resistance2: 39.48
Pivot: 23.33
Moving Average: MA(5): 11.02     MA(20): 27.04
MA(100): 41.43     MA(250): 58.62
MACD: MACD(12,26): -7.38     Signal(9): -5.38
Stochastic oscillator: %K(14,3): 3.64     %D(3): 3.50
RSI: RSI(14): 16.70
52-week: High: 83.10  Low: 10.00  Change(%): -84.0
Average Vol(K): 3-Month: 81606  10-Days: 330639

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ANAB has closed above bottom band by 27.1%. Bollinger Bands are 324.9% wider than normal. The large width of the bands suggest high volatility as compared to ANAB's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

AnaptysBio Earnings: Why ANAB Stock Is Plunging 72%
AnaptysBio (ANAB) earnings for the antibody development company's third quarter of 2019 have ANAB stock taking a dive on Friday.

AnaptysBio (NASDAQ:ANAB) Stock Rating Lowered by Wedbush
AnaptysBio (NASDAQ:ANAB) was downgraded by equities researchers at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday, The Fly reports. Other analysts have also issued research reports about the company. Stifel Nicolaus restated a “hold” rating on shares of AnaptysBio in a report on Monday, September […]

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27.13
Shares Float (M) 21.78
% Held by Insiders 1.32
% Held by Institutions 113.23
Shares Short (K) 3450
Shares Short P. Month (K)

Stock Financials

EPS -3.490
Book Value (p.s.) 15.530
PEG Ratio
Profit Margin
Operating Margin -2096.74
Return on Assets (ttm) -13.4
Return on Equity (ttm) -20.4
Qtrly Rev. Growth
Gross Profit (p.s.) -1.887
Sales Per Share
EBITDA (p.s.) -3.847
Qtrly Earnings Growth
Operating Cash Flow (M) -66.00
Levered Free Cash Flow (M) -36.38

Stock Valuations

P/E -3.16
P/E Growth Ratio
P/BV 0.71
P/S 58.10
P/CF -4.54

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.